Chemo-Induced Neuropathy ICD-10-CM Codes

Chemo-Induced Neuropathy ICD-10-CM Codes

Explore ICD-10-CM codes for chemo-induced neuropathy, including G62.0, symptoms, treatment options, and proper documentation for adverse drug effects.

By Audrey Liz Perez on Jul 16, 2025.

Fact Checked by Ericka Pingol.

Use Code

What are Chemo-Induced Neuropathy ICD-10-CM Codes?

Chemo-induced neuropathy, also known as chemotherapy-induced peripheral neuropathy, is a recognized adverse effect of cancer treatment. Although ICD-10-CM does not feature a diagnosis code that explicitly names "chemo-induced neuropathy," there are valid codes applicable to this condition.

The most appropriate ICD-10 code is:

  • G62.0 – Drug-induced polyneuropathy: This code applies to polyneuropathy due to drug use, which includes chemotherapy agents known to cause nerve damage. G62.0 falls under diseases of the peripheral nervous system, and should be used to document disorders due to drug toxicity affecting peripheral nerves.

Note: Always assign an additional code to identify the drug (e.g., cisplatin or vincristine), if known, to specify the adverse effect if applicable. The appropriate fifth or sixth character may be required depending on the drug and setting.

Which Chemo-Induced Neuropathy ICD-10-CM Codes are billable?

Yes. The ICD-10-CM code G62.0 – Drug-induced polyneuropathy is a billable diagnosis code. It is valid for HIPAA-covered transactions and commonly used to report neuropathy related to chemotherapy.

You may also need to document:

  • T45.1X5A– Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
  • T45.1X5D– Subsequent encounter
  • T45.1X5S– Sequela

These codes help ensure accurate reporting of adverse effects caused by chemotherapy agents, including polyneuropathy due to drugs, and meet coding compliance standards set by institutions such as the National Cancer Institute.

Clinical information

Peripheral neuropathy is the term used to describe damage to nerves outside the brain and spinal cord. These nerves are referred to as peripheral nerves, and their functions include helping us control muscle movements and communicating sensory information to the brain.

Chemo-induced neuropathy is a type of peripheral neuropathy caused by chemotherapy-related drugs, such as oxaliplatin, docetaxel, vincristine, bortezomib, cisplatin, and paclitaxel, to mention a few. These have toxic effects that can damage the nerves.

A person with chemo-induced neuropathy will likely have the following symptoms:

  • Muscle weakness
  • Loss of balance
  • Loss of coordination
  • Trouble reaching, grasping, and manipulating objects with hands
  • Pain (aching, burning, sharp, or shooting)
  • Sensitivity to pressure
  • Sensitivity to pain’
  • Sensitivity to temperature
  • Sensitivity to touch
  • Numbness
  • Tingling

Synonyms include:

  • Chronic painful polyneuropathy following chemotherapy
  • Painful polyneuropathy following chemotherapy
  • Neuropathy post-chemotherapy
  • Neuropathy following chemotherapy
  • Painful neuropathy following chemotherapy
  • Chronic neuropathy following chemotherapy
  • Polyneuropathy post-chemotherapy
  • Chemotherapy-induced neuropathy ICD 10
  • ICD 10 code for chemically induced neuropathy
  • ICD 10 chemo-induced neuropathy
  • Chemo-induced peripheral neuropathy ICD 10
  • ICD 10 code for chemotherapy-induced peripheral neuropathy

Related ICDs

EHR and practice management software

Get started for free

*No credit card required

Free

$0/usd

Unlimited clients

Telehealth

1GB of storage

Client portal text

Automated billing and online payments